A Phase 1, Single Center Randomized, Three-way Crossover, Double-blinded, Placebo- And Moxifloxacin-controlled Thorough Qt (Tqt) Study To Determine The Effects Of Sertraline (Zoloft (Registered)) On The Cardiac Repolarization In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Sertraline (Primary)
- Indications Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Social phobia
- Focus Adverse reactions
- Acronyms Zoloft
- Sponsors Pfizer
- 28 Sep 2016 Status changed from recruiting to completed.
- 02 Feb 2016 New trial record
- 28 Jan 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov record.